These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2104929)

  • 21. Chronic industrial exposure to lead in 63 subjects. II. Evaluation of chelation therapy.
    Strickland GT; Hwang YF; Chang NK; Blackwell RQ
    Southeast Asian J Trop Med Public Health; 1976 Dec; 7(4):569-74. PubMed ID: 828980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
    Besunder JB; Super DM; Anderson RL
    J Pediatr; 1997 Jun; 130(6):966-71. PubMed ID: 9202621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imported occupational lead poisoning: report of four cases.
    Petracca M; Scafa F; Boeri R; Flachi D; Candura SM
    Med Lav; 2013; 104(6):428-33. PubMed ID: 24640829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical responses to provocative chelation by edetate disodium calcium.
    Teisinger J
    Arch Environ Health; 1971 Oct; 23(4):280-3. PubMed ID: 4999977
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings.
    Alam ZH; Ujueta F; Arenas IA; Nigra AE; Navas-Acien A; Lamas GA
    Int J Environ Res Public Health; 2020 Jun; 17(13):. PubMed ID: 32610666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of childhood lead poisoning: clinical impact and cost-effectiveness.
    Glotzer DE; Freedberg KA; Bauchner H
    Med Decis Making; 1995; 15(1):13-24. PubMed ID: 7898292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.
    Lee BK; Schwartz BS; Stewart W; Ahn KD
    Occup Environ Med; 1995 Jan; 52(1):13-9. PubMed ID: 7697134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chelation therapy to treat lead toxicity in children.
    Wegmann K
    Minn Med; 1992 Nov; 75(11):25-7. PubMed ID: 1331737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.
    Schwartz BS; McGrail MP; Stewart W; Pluth T
    Occup Environ Med; 1994 Oct; 51(10):669-73. PubMed ID: 8000491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
    Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of urinary lead concentration in interpretation of the EDTA mobilization test.
    Shannon M; Grace A; Graef J
    Vet Hum Toxicol; 1989 Apr; 31(2):140-2. PubMed ID: 2494797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult lead poisoning.
    Zatlin GS; Senaldi EM; Bruckheim AH
    Am Fam Physician; 1985 Oct; 32(4):137-43. PubMed ID: 3931445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urinary lead elimination after treatment with calcium disodium ethylenediamine tetraacetate].
    SALVINI M; VIDALI U
    Folia Med (Napoli); 1955 Jun; 38(6):579-92. PubMed ID: 13262209
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations.
    Graziano JH; Lolacono NJ; Meyer P
    J Pediatr; 1988 Oct; 113(4):751-7. PubMed ID: 2845043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of methionine and zinc supplementation during chelation of lead in rats.
    Tandon SK; Singh S; Flora SJ
    J Trace Elem Electrolytes Health Dis; 1994 Jun; 8(2):75-7. PubMed ID: 7881280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compared effects of high oral Mg supplements and of EDTA chelating agent on chronic lead intoxication in rabbits.
    Soldatovic D; Vujanovic D; Matovic V; Plamenac Z
    Magnes Res; 1997 Jun; 10(2):127-33. PubMed ID: 9368233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Children with moderately elevated blood lead levels: a role for other diagnostic tests?
    Markowitz ME; Clemente I; Rosen JF
    Environ Health Perspect; 1997 Oct; 105(10):1084-8. PubMed ID: 9349832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.